India Pesticides Limited (IPL) announced its financial results for the quarter and year ended March 31, 2025.
FY25 Revenue: ₹843 Cr, up by 21.3% YoY.
FY25 EBITDA: ₹134 Cr with a margin of 15.9%.
FY25 Net Profit: ₹82 Cr with a PAT margin of 9.7%.
Q4 FY25 Total Income: ₹211 Cr, up 62.1% YoY.
Q4 FY25 EBITDA: ₹35 Cr, up 373.9% YoY with a margin of 16.6%.
Q4 FY25 Net Profit: ₹22 Cr, up 1,953.8% YoY with a PAT margin of 10.3%.
Technical and API constituted 66% of the total revenue.
The company commissioned an expanded intermediate PEDA facility.
Capacity expansion to 8,500 MT per annum is on track for completion by Q2 FY26.
Capital expenditure of ₹52 crore is planned for existing manufacturing facilities and ₹64 crore for Shalvis Specialities Limited in FY26.
Management Commentary (Mr. Anand S. Agarwal, Director, Founder & Promoter): IPL demonstrated resilience and delivered a strong performance despite headwinds in international markets. The company achieved revenue of ₹843 crore, reflecting a growth of 21.3% YoY, primarily volume-led. IPL is increasingly recognized as a trusted partner, with all major Indian companies sourcing key molecules from them. The company remains committed to executing its strategic priorities and accelerating its growth trajectory, and is optimistic about the long-term prospects.